-
Medical journals
- Career
Gastroenterology and Hepatology - Issue 1/2019
Editorial
5News in 2019Lukáš M.
IDB: Original Article
25Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practiceKolar M., Ďuricová D., Bortlík M., Pudilova K., Hrubá V., Machková N., Mitrová K., Malickova K., Lukas M. jr., Vasatko M., Vanickova R., Lukas M.
32Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel diseasePudilova K., Kolar M., Ďuricová D., Malickova K., Hrubá V., Machková N., Vanickova R., Mitrová K., Lukas M., Vasatko M., Bortlík M.
IBD: Review Article
37Inflammatory bowel disease and medical assessment serviceMatějková P., Vítková Z.
IBD: Case Report
43Treatment of a pregnant Crohn’s disease patient with ustekinumab: a case reportLukešová L., Nedbalová L., Šerclová Z.
46Ileocaecal Crohn’s disease and familial adenomatous polyposis in one patient – a case reportCan V., Marek F., Kala Z., Poredská K., Kroupa R., Tvrdikova E., Andrasina T., Prochazka V., Kunovsky L.
Clinical and Experimental Gastroenterology: Case Report
52Surprising etiology of terminal common bile duct strictureVašíček J., Horný I.
Clinical and Experimental Gastroenterology: Original Article
56Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal refluxL. Nosáková, Ďuriček M., P. Bánovčin Jr., Gburová D., Lipták P., Hyrdel R.
Digestive Endoscopy: Original Article
62Does abdominal compression improve the success rate of and tolerance to colonoscopy?Kojecký V., Havlíčková Z., Gabrielová M., Haasová J., Machalová M., Kopečná H., Štekovičová B.
Chapters from internal medicine: Review Article
66Toxic and drug damage of the liver and kidneysTeplan V., Ševela K.
82
Gastroenterology and Hepatology
2019 Issue 1
Most read in this issue- Clensia® – the first combined cleansing agent with simeticone
- Toxic and drug damage of the liver and kidneys
- Surprising etiology of terminal common bile duct stricture
- Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career